- Home
- ALZN vs SOAR Comparison
ALZN vs SOAR Comparison
Compare ALZN & SOAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- SOAR
- Stock Information
- Founded
- ALZN 2016
- SOAR 2021
- Country
- ALZN United States
- SOAR United States
- Employees
- ALZN N/A
- SOAR N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- SOAR Blank Checks
- Sector
- ALZN Health Care
- SOAR Finance
- Exchange
- ALZN Nasdaq
- SOAR Nasdaq
- Market Cap
- ALZN 8.2M
- SOAR 9.4M
- IPO Year
- ALZN 2021
- SOAR N/A
- Fundamental
- Price
- ALZN $2.53
- SOAR $2.15
- Analyst Decision
- ALZN Strong Buy
- SOAR
- Analyst Count
- ALZN 1
- SOAR 0
- Target Price
- ALZN $42.00
- SOAR N/A
- AVG Volume (30 Days)
- ALZN 170.2K
- SOAR 1.1M
- Earning Date
- ALZN 09-10-2025
- SOAR 11-17-2025
- Dividend Yield
- ALZN N/A
- SOAR N/A
- EPS Growth
- ALZN N/A
- SOAR N/A
- EPS
- ALZN N/A
- SOAR N/A
- Revenue
- ALZN N/A
- SOAR $96,397,000.00
- Revenue This Year
- ALZN N/A
- SOAR N/A
- Revenue Next Year
- ALZN N/A
- SOAR N/A
- P/E Ratio
- ALZN N/A
- SOAR N/A
- Revenue Growth
- ALZN N/A
- SOAR 309.80
- 52 Week Low
- ALZN $2.06
- SOAR $1.14
- 52 Week High
- ALZN $17.10
- SOAR $19.06
- Technical
- Relative Strength Index (RSI)
- ALZN 52.36
- SOAR 63.41
- Support Level
- ALZN $2.33
- SOAR $1.70
- Resistance Level
- ALZN $2.55
- SOAR $2.22
- Average True Range (ATR)
- ALZN 0.10
- SOAR 0.18
- MACD
- ALZN 0.02
- SOAR 0.04
- Stochastic Oscillator
- ALZN 66.07
- SOAR 67.12
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About SOAR Volato Group Inc.
Volato Group Inc operates an aircraft ownership program, provides ad-hoc charter flights, sells deposit products, and manages aircraft for owners in the private aviation industry. It offers fractional ownership, aircraft management, jet cards, deposit, and charter programs. The company's fractional programs provides flexible hours and a revenue share for owners in a fleet of HondaJets, optimized for missions of up to four passengers.